Community pharmacy workforce figures issued

Community pharmacy workforce figures issued

June 20 2018 Data for the community pharmacy workforce in England indicates that 96,506 people...

Scottish pharmacy contract sees Global Sum increase 1.46%

Scottish pharmacy contract sees Global Sum increase 1.46%

June 18 2018 Funding for the community pharmacy contract in Scotland has been announced with a...

National Minor Ailment Service still some way off, indicates minister

National Minor Ailment Service still some way off, indicates minister

June 15 2018 A nationally commissioned Minor Ailments Service (MAS) as part of the pharmacy...

Pharmacy Integration Fund: £23.6m diverted “to support other parts of NHS”

Pharmacy Integration Fund: £23.6m diverted “to support other parts of NHS”

June 14 2018 Over half of the £42 million funding allocated to develop pharmacy services in...

Wales announces £100m to shake up NHS and social care services

Wales announces £100m to shake up NHS and social care services

June 14 2018 Wales is to undergo a significant overhaul of NHS and social care services, the...

  • Community pharmacy workforce figures issued

    Community pharmacy workforce figures issued

    Wednesday, 20 June 2018 18:33
  • Scottish pharmacy contract sees Global Sum increase 1.46%

    Scottish pharmacy contract sees Global Sum increase 1.46%

    Monday, 18 June 2018 17:23
  • National Minor Ailment Service still some way off, indicates minister

    National Minor Ailment Service still some way off, indicates minister

    Friday, 15 June 2018 18:22
  • Pharmacy Integration Fund: £23.6m diverted “to support other parts of NHS”

    Pharmacy Integration Fund: £23.6m diverted “to support other parts of NHS”

    Thursday, 14 June 2018 14:12
  • Wales announces £100m to shake up NHS and social care services

    Wales announces £100m to shake up NHS and social care services

    Thursday, 14 June 2018 14:06

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a psoriasis image cbAugust 22 2017

Dovonex Psoriasis 50microgram/g Ointment is to be made available as an over the counter medicine. 

 The MHRA announced that the ointment, containing calcipotriol will be available in 60g tubes for adults with mild to moderate plaque psoriasis which has been previously diagnosed by a doctor.

The packaging will be specially designed, as part of the licensing requirement for the Pharmacy medicine version of Dovonex, the MHRA said. “Pharmacists and their staff will be able to provide suitable advice to the patient to ensure that the product is suitable for them. The outer packaging and the patient information leaflet also include an image of plaque psoriasis which will help both pharmacists and patients in this respect.”

An estimated 2% of the population have psoriasis. The MHRA issued its consultation on the POM to P switch in March. It has now published the responses it received to the consultation, when announcing that market authorisation had been approved.

Dr Sarah Branch, MHRA’s Deputy Director of VRMM, said: “Psoriasis is a chronic disease which can have a major impact on people’s quality of life. By making this medicine more widely available, patients will be able to treat flare ups quickly without the need for a prescription.

Royal Pharmaceutical Society President Ash Soni added: “Pharmacists are already able to sell products for the treatment of psoriasis with appropriate advice on management, application and side effects. We welcome the addition of Dovonex Psoriasis Ointment to the range of products available.

“Pharmacists are more easily accessible than doctors and trained to give advice on medicine use, make sure the chosen medicine is appropriate and check if a person needs to see another health professional. This is an important patient benefit and we would like to see more medicine available through pharmacy in future.”

Links:
MHRA announcement   
Dovonex Consultation and responses      

Business News

June 22 2018 A review into the scheduling of cannabis for medicinal purposes will look for “significant medical and therapeutic benefits” before a decision is made.
June 19 2018 A practice-based audit will seek to explore community pharmacy’s contribution in supporting girls and women of childbearing potential who need to take valproate medicines. Launched by...